Google DeepMind unveils next generation of drug discovery AI model


A Google logo is seen at the company's headquarters in Mountain View, California, U.S., November 1, 2018. REUTERS/ Stephen Lam/File Photo

LONDON (Reuters) - Google Deepmind has unveiled the third major version of its "AlphaFold" artificial intelligence model, designed to help scientists design drugs and target disease more effectively.

In 2020, the company made a significant advance in molecular biology by using AI to successfully predict the behaviour of microscopic proteins.

Uh-oh! Daily quota reached.


Experience an ad-free unlimited reading on both web and app.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

   

Next In Tech News

AI echo chambers: Chatbots feed our own bias back to us, study finds
Musk, Indonesian health minister, launch Starlink for health sector
Apple brings eye tracking to iPhone and iPad in accessibility update
What do Google’s AI updates mean for everyday users?
Preview: ‘MechWarrior 5: Clans’ takes a more cinematic approach to its giant robot campaign
Britain's M&S apologises after website and app hit by 'technical issue'
Honey, I love you. Didn’t you see my Slack about it?
The architects of ‘Hades’ strive to bewitch gamers again
A pithy YouTube celebrity’s plea: Buy this video game
Coming soon: Control your smartphone with facial expressions

Others Also Read